Nomoto, H., Takahashi, A., Nakamura, A., Kurihara, H., Takeuchi, J., Nagai, S., Taneda, S., Miya, A., Kameda, H., Cho, K. Y., Miyoshi, H., & Atsumi, T. (2022). add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study). BMJ open diabetes research and care, 10(6), . http://access.bl.uk/ark:/81055/vdc_100169537917.0x000004